Last reviewed · How we verify
NCT04715737
Differential Effects of Vasopressin and Oxytocin on Attention Control
NA trial testing Vasopressin in Healthy in 160 participants. Completed in 1 January 2021.
1 January 2021
Quick facts
| Lead sponsor | University of Electronic Science and Technology of China |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 160 |
| Start date | 19 December 2017 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Vasopressin — full drug profile →
- Oxytocin (OXYTOCIN) — full drug profile →
- Placebo
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
University of Electronic Science and Technology of China
Who can join
Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of the present study is to investigate whether intranasal vasopressin (20IU) and oxytocin (24IU) have differential effects on attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04715737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vasopressin
Trials testing the same drug.
- NCT06426407 — Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator · terminated
- NCT06547892 — Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU · Phase 2 · recruiting
- NCT06419075 — Tranexamic Acid in Vaginal Reconstructive Surgery · Phase 4 · withdrawn
- NCT06290596 — Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy · Phase 4 · unknown
- NCT06329037 — The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study · NA · recruiting
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of Electronic Science and Technology of China trials
Trials by the same sponsor.
- NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
- NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
- NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
- NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
- NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04715737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
- Last refreshed: 22 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04715737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing